Renowned Shoulder Surgeon, Dr. Ken Yamaguchi, Joins Osso VR’s Advisory Board

Virtual reality surgical training company adds world-class surgeon to its growing advisory team

SAN FRANCISCO, Feb. 17, 2021 Osso VR, the leading VR surgical training platform, today announces the addition of Dr. Ken Yamaguchi, MBA, a renowned shoulder surgeon and chief medical officer (CMO) at Centene Corporation, a $110B Fortune 25 healthcare company, to the company’s advisory board

Dr. Yamaguchi completed his residency training at George Washington University. He then completed fellowship training in shoulder surgery at the internationally recognized Shoulder Service at the Columbian Presbyterian Medical Center in New York, followed by supplemental training in elbow surgery at the Mayo Clinic. Dr. Yamaguchi founded and remains active in one of the top shoulder and elbow fellowships in the world. In 2012, Dr. Yamaguchi received his MBA from the Olin Business School at Washington University in St. Louis. In addition to his current role as CMO at Centene, Dr. Yamaguchi is the Sam & Marilyn Fox Distinguished Professor at Washington University.

“I am a strong advocate for Osso VR’s mission, the technology behind the platform, and the company’s fantastic team. In light of today’s turbulent healthcare environment, Osso VR is providing the foundation in order to secure our supply of proficient surgeons and ensuring they are utilizing the best technologies and techniques for patients,” said Dr. Yamaguchi.  

Osso VR’s surgical training technology provides on-demand, educational experiences that are effective, repeatable and measurable to help surgeons reach proficiency with new procedures and devices. The platform has become integral to surgical training programs worldwide and is currently used by 20+ leading teaching hospitals and 14 top medical device companies in 20 countries. 

“From top to bottom, we focused on pulling together the strongest team of clinical, medical device, technology and art experts from all over the globe, and we are extremely proud of what we’ve built together at Osso VR,” said Justin Barad, MD, CEO and co-founder of Osso VR. “We are extremely humbled to add Dr. Yamaguchi to our board and look forward to using his world-class expertise to scale our platform, reach more patients and ultimately allow medicine to thrive in the new normal.” 

To build its clinically validated VR platform, Osso VR assembled a team of clinical, medical device and technology experts from leading institutions, including Apple, Industrial Light & Magic, Google, Microsoft, Sony, and Electronic Arts. Osso VR has attracted the best in medicine to form its advisory board, with healthcare leaders from Washington University, the Hospital for Special Surgery, Mayo Clinic, Harvard and Stanford. 

For more information, visit

About Osso VR

Osso VR is an award-winning, clinically validated surgical training platform designed for medical device companies, practicing surgeons, residents and medical students of all skill levels. Using immersive VR technology, the scalable platform offers a realistic, hands-on training environment that leads to real world performance gains and ultimately improved patient outcomes. Osso VR is the first training platform to incorporate assessment into its modules, objectively measuring the trainee’s knowledge of steps, level of precision and overall efficiency throughout the procedure providing a benchmark for proficiency.

Led by UCLA and Harvard trained orthopedic surgeon Justin Barad, MD, the Osso VR team has a deep background in clinical care, medical technology, and VR development. To learn more, visit:

Osso VR – Virtual Reality Surgical Training Platform Osso VR is a surgical training and assessment platform that allows surgeons, sales teams, and hospital staff to train and assess using advanced virtual reality.

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button